GAVI to deploy six-in-one vaccine to lower-income countries

The Board of Gavi, the Vaccine Alliance today outlined a set of decisions that will expand the portfolio of vaccine programmes available to lower-income countries in the coming years.

It also committed to providing COVID-19 vaccines to high-risk groups until 2025 and approved an innovative plan to enable pilot investment in reserves of investigational candidate vaccines if appropriate candidate vaccines become available, helping respond more quickly to outbreaks of Marburg and Ebola Sudan viruses.

Expanding access to new vaccines

When the Alliance was founded in 2000, it supported vaccines against just three diseases; today it supports vaccines against 19. Continuing this trend, this week’s Board meeting saw the Alliance discuss and approve plans that will see lower-income countries access new vaccines in the coming years.

Hexavalent vaccine: The Board approved Gavi investment in the six-in-one vaccine – a combination of the pentavalent vaccine, which protects against diphtheria, tetanus, pertussis (whooping cough), hepatitis B and Haemophilus influenzae type b, and the inactivated polio vaccine (IPV). A window will now be opened for countries to apply for funding.

By New Business Ethiopia

https://newbusinessethiopia.com/health/gavi-to-deploy-six-in-one-vaccine-to-lower-income-countries/